Global Insulin Delivery Devices Market - Market Size, Share & Industry Trends, Growth Analysis Report By Product Type, By Consumption and Forecast 2019 - 2025


DescriptionTable of ContentList of TablesList of Figures
Introduction

Insulin Delivery Devices Market was valued at USD X.X Billion in 2018 and is projected to reach USD X.X billion by 2025, at a CAGR of X.X % from 2019-2025. Insulin delivery devices including syringes, pens, pumps, and jet injectors are used to deliver insulin to diabetic patients. One of the foremost factors contributing to the growth of the market is the surging number of diabetics due to aging, obesity, and unhealthy lifestyles. 
According to the WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese. Risk factors, such as obesity and being overweight are highly linked to the incidence of diabetes, which is rising by epidemic proportions, thus engendering a high prevalence of diabetes. 

Geographical Overview

At a global level, North America region was holding the highest market share in 2018. Whereas, Asia Pacific region is considered as the fastest growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of Insulin Delivery Devices Market with its high population base. North America is estimated to reign the insulin delivery devices industry in the year 2015. The rising diabetic population and the accessibility of technologically advanced devices are the factors contributing to the high market growth in North America. 

Segmental Overview
Insulin Delivery Devices Market is segmented as per below specifications -  

By Product Type: 
• Insulin syringes
• Insulin pens
• Insulin pumps
• Insulin injectors


By Consumption: 
• Type A
• Type B

By Distribution Channel: 
• Hospitals
• Homecare
• Others


Competitor Analysis
Insulin Delivery Devices Market has presence of some of the key major players across globe which includes
• Novo Nordisk A/S 
• Sanofi 
• Medtronic 
• Becton 
• Dickinson 
• Eli Lilly and Company
• Abbott
• F. Hoffmann-La Roche Ltd. 

These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.  

By Geographical Locations: 
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China 
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific 
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA

Highlights of the report
What is Insulin Delivery Devices Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation 
Market size projection based on Historical & current market trends 
Market share analysis and key strategies adopted by leading Players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations